C. Green

发表

Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party.

T. A. Lister, J. Fitzgibbon, R. Hills, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis

R. Hills, D. Linch, D. Bowen, 2009, Leukemia.

Comparison of Multidimensional Flow Cytometry With Standard Morphology for Evaluation of Early Marrow Response in Pediatric Acute Lymphoblastic Leukemia

J. Radich, W. Leisenring, S. Meshinchi, 2001, Journal of pediatric hematology/oncology.

the mutation mutations depends on the location of IDH2 The prognostic significance of

R. Hills, D. Linch, A. Burnett, 2012 .

Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.

R. Hills, D. Linch, A. Burnett, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA.

R. Hills, D. Linch, A. Goldstone, 2010, Blood.

The prognostic significance of IDH 1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT 3 / ITD status

R. Hills, D. Linch, A. Burnett, 2010 .

GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations

J. Fitzgibbon, R. Hills, D. Linch, 2013, British journal of haematology.

The Impact of FLT3-ITD and NPM1 Mutational Status on the Outcome of ATRA Therapy in Patients with Non-APL AML: Results of the UK MRC AML12 Trial

R. Hills, D. Linch, M. Lazenby, 2008 .

Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2

A. Futreal, A. Flanagan, M. Eskandarpour, 2011, Nature Genetics.

The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status.

R. Hills, D. Linch, A. Burnett, 2010, Blood.

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

Adam J Mead, Robert K Hills, A. Mead, 2008, Blood.

Studies on CEBPA mutations in acute myeloid leukaemia

C. Green, Claire L. Green, 2012 .

patients with acute myeloid leukemia and interaction with NPM1 mutations in a large cohort of young adult The impact of FLT3 internal tandem duplication mutant level, number, size

A. Mead, R. Hills, D. Linch, 2013 .

Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated with Chemoresistance in Normal Karyotype Acute Myeloid Leukemia.

T. A. Lister, J. Fitzgibbon, R. Hills, 2007 .

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation.

R. Hills, D. Linch, A. Burnett, 2011, Blood.

Most acute myeloid leukaemia patients with intermediate mutant FLT3/ITD levels do not have detectable bi‐allelic disease, indicating that heterozygous disease alone is associated with an adverse outcome

D. Linch, R. Gale, C. Green, 2008, British journal of haematology.